Methods for Long-Term Follow-Up of HIV-Infected Patients
HIV 感染者的长期随访方法
基本信息
- 批准号:7197314
- 负责人:
- 金额:$ 31.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-01 至 2008-12-09
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAnti-Retroviral AgentsAntiviral resistanceApplications GrantsBiological MarkersCD4 Lymphocyte CountClinicalCommunitiesComplexDevelopmentDimensionsEvolutionFailureGeneticGenetic ModelsGenotypeGoalsGrantHIVHIV-1Immune responseInvestigationJointsLong-Term EffectsMeasurementMeasuresMedicalMethodologyMethodsModelingMutationOutcomePathway interactionsPatientsPatternPhenotypeProcessRecording of previous eventsResistanceResistance developmentStandards of Weights and MeasuresSurrogate EndpointTimeViralViral Drug ResistanceViral Load resultVirusbasecomparison groupconceptfitnessfollow-upinterestmarkov modelmethod developmentresponsestatisticssurrogacytherapy developmenttreatment effectvirus genetics
项目摘要
DESCRIPTION (provided by applicant): The goal of this grant application is development of methods for understanding the consequences of antiretroviral treatment for the development of antiviral resistance. The development of resistance results from the acquisition of mutations over time-a process that both reflects and contributes to amount of replicating virus and perhaps also the fitness of virus. We intend to model these process jointly to study the complex co-evolution of viral genotype and such longitudinal measures as viral load or fitness, and CD4 count. Specifically our aims are: 1) Inclusion of time-varying covariates in hidden Markov models of viral genetic progression to examine the impact of viral diversity, viral load, and other factors on pathways to antiviral resistance. 2) Joint modeling of genetic pathways to resistance (using hidden Markov models) and time to virological failure, in settings where the genetic state is know with error. 3) Semiparametric methods for relating viral genotype to phenotype and to investigate the impact of specific mutations in the presence of others. 4) U-statistic approaches for two group comparisons of repeated measures of viral load, when times of measurement are arbitrary. 5) Assessing surrogacy of high-dimensional longitudinal markers subject to measurement error and missingness. Aim 1) investigates how factors like viral load, treatment, adherence history or other time-varying factors influence the pathways to resistance taken by the virus. Aim 2) investigates the influence of genetic pathway on the time course of longitudinal measures, like viral load or fitness. Aim 3) extends the methods developed in the last grant period to relate genotype to any response variable. The new methods are semi parametric; they should be more robust to nonnormality of errors and more powerful than the previous methods. Aim 4) arose from consideration of the problems raised in an AIEDRP concept sheet to investigate the impact of primary resistance mutations on the virological response to treatment. Aim 5) investigates the degree to which information on short-term response of viral load and on acquisition of resistance mutations can serve as surrogates for longer term clinical outcomes.
描述(由申请人提供):本资助申请的目标是开发方法,以了解抗逆转录病毒治疗对抗病毒药物耐药性发展的影响。耐药性的产生源于随着时间的推移而获得的突变——这一过程既反映了病毒复制的数量,也可能有助于病毒的适应性。我们打算共同建立这些过程的模型,以研究病毒基因型的复杂共同进化,以及诸如病毒载量或适应度以及CD4计数等纵向测量。具体来说,我们的目标是:1)在病毒遗传进展的隐马尔可夫模型中包含时变协变量,以检查病毒多样性,病毒载量和其他因素对抗病毒抗性途径的影响。2)在遗传状态已知但存在错误的情况下,对抗性遗传途径(使用隐马尔可夫模型)和病毒学失败时间进行联合建模。3)将病毒基因型与表型联系起来的半参数方法,以及在其他存在的情况下研究特定突变的影响。4)在任意测量次数的情况下,用于重复测量病毒载量的两组比较的u -统计方法。5)评估测量误差和缺失的高维纵向标记的替代性。目的1)调查诸如病毒载量、治疗、依从史或其他时变因素如何影响病毒采取的耐药途径。目的2)研究遗传途径对纵向测量时间过程的影响,如病毒载量或适应度。目标3)扩展上一个拨款期开发的方法,将基因型与任何反应变量联系起来。新方法是半参数的;它们应该对错误的非正态性更健壮,并且比以前的方法更强大。目标4)源于对AIEDRP概念表中提出的问题的考虑,该概念表旨在调查原发性耐药突变对治疗的病毒学反应的影响。目的5)调查病毒载量的短期反应和获得耐药突变的信息在多大程度上可以作为长期临床结果的替代品。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VICTOR GERARD DEGRUTTOLA其他文献
VICTOR GERARD DEGRUTTOLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VICTOR GERARD DEGRUTTOLA', 18)}}的其他基金
Methods to Advance the HIV Prevention Research Agenda
推进艾滋病毒预防研究议程的方法
- 批准号:
9188055 - 财政年份:2015
- 资助金额:
$ 31.1万 - 项目类别:
Methods for Long-Term Follow-Up of HIV-Infected Patients
HIV 感染者的长期随访方法
- 批准号:
6622564 - 财政年份:2002
- 资助金额:
$ 31.1万 - 项目类别:
Methods for Long-Term Follow-Up of HIV-Infected Patients
HIV 感染者的长期随访方法
- 批准号:
7622479 - 财政年份:2002
- 资助金额:
$ 31.1万 - 项目类别:
Methods to Advance the HIV Prevention Research Agenda
推进艾滋病毒预防研究议程的方法
- 批准号:
8211677 - 财政年份:2002
- 资助金额:
$ 31.1万 - 项目类别:
Methods for Long-Term Follow-Up of HIV-Infected Patients
HIV 感染者的长期随访方法
- 批准号:
6947623 - 财政年份:2002
- 资助金额:
$ 31.1万 - 项目类别:
Methods for Long-Term Follow-Up of HIV-Infected Patients
HIV 感染者的长期随访方法
- 批准号:
7744052 - 财政年份:2002
- 资助金额:
$ 31.1万 - 项目类别:
Methods for Long-Term Follow-Up of HIV-Infected Patients
HIV 感染者的长期随访方法
- 批准号:
6450475 - 财政年份:2002
- 资助金额:
$ 31.1万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Fellowship Programs














{{item.name}}会员




